Private Eye

Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$432/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Off-market insider buying at Experion Holdings (:EXP)

Updated Wednesday Nov 20, 2019 05:06 AM EDT

Jason Garnett, CEO and Director, acquired 1,666,667 Common Shares on a direct ownership basis at a price of $0.150 through a prospectus or prospectus exempt offering on November 18th, 2019. This represents a $250,000 investment into the company's shares and an account share holdings change of greater than 100%.

Experion Holdings is in the Pharmaceuticals Sub Industry Group under the Healthcare Sector.

Experion Holdings Ltd., formerly Viridium Pacific Group Ltd, is a Canada-based company that is engaged in the medical cannabis sector. Viridium Pacific Group Ltd owns a controlling interest in Experion Biotechnologies Inc (Experion). Experion Biotechnologies Inc is a science-led company that conducts business in the cannabis production industry. Experion Biotechnologies Inc holds a license to produce cannabis pursuant to the Access to Cannabis for Medical Purposes Regulations (ACMPR), granted by Health Canada. Experion Biotechnologies Inc's objective is the: production of whole plant, starter material; production of dried marijuana flowers, as well as the distribution of its production, including the wholesale distribution of its starter material to licensed growers and marijuana flower product for wholesale and retail distribution across Canada.

INK Edge Outlook

CONDITIONS:
Latest
6 months ago
1 year ago
Overall
N/A
N/A
N/A
The INK Edge Outlook is a quantitative process that ranks a stock based on our V.I.P. criteria.
View outlooks on all Canadian listed stocks at inkresearch.com.
Two-week free trial for first time users.
Go to (EXP)'s company page

Comment On!

140
Upload limit is up to 1mb only
To post messages to your Socail Media account, you must first give authorization from the websites. Select the platform you wish to connect your account to CanadianInsider.com (via Easy Blurb).

Comment On!

No Comments

Twitter

Search (past week) for $.CA

  • No tweets found

Stocktwits